APA (7th ed.) Citation

Isik, B., Davey, M. G., Jaffer, A. A., Buckley, J., Brown, J. A. L., Baban, C., . . . Tormey, S. (2025). Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer. Breast Cancer Research and Treatment, 210(3), 783-790. https://doi.org/10.1007/s10549-025-07615-8

Chicago Style (17th ed.) Citation

Isik, Burce, Matthew G. Davey, Alisha A. Jaffer, Juliette Buckley, James A. L. Brown, Chwanrow Baban, Bridget Anne Merrigan, and Shona Tormey. "Assessing the Clinical Utility of Pre-operative Neutrophil–lymphocyte Ratio as a Predictor of Clinicopathological Parameters in Patients Being Treated for Primary Breast Cancer." Breast Cancer Research and Treatment 210, no. 3 (2025): 783-790. https://doi.org/10.1007/s10549-025-07615-8.

MLA (9th ed.) Citation

Isik, Burce, et al. "Assessing the Clinical Utility of Pre-operative Neutrophil–lymphocyte Ratio as a Predictor of Clinicopathological Parameters in Patients Being Treated for Primary Breast Cancer." Breast Cancer Research and Treatment, vol. 210, no. 3, 2025, pp. 783-790, https://doi.org/10.1007/s10549-025-07615-8.